Your browser doesn't support javascript.
loading
Characterization of patients with long-term responses to rucaparib treatment in recurrent ovarian cancer.
Swisher, Elizabeth M; Kristeleit, Rebecca S; Oza, Amit M; Tinker, Anna V; Ray-Coquard, Isabelle; Oaknin, Ana; Coleman, Robert L; Burris, Howard A; Aghajanian, Carol; O'Malley, David M; Leary, Alexandra; Welch, Stephen; Provencher, Diane; Shapiro, Geoffrey I; Chen, Lee-May; Shapira-Frommer, Ronnie; Kaufmann, Scott H; Goble, Sandra; Maloney, Lara; Kwan, Tanya; Lin, Kevin K; McNeish, Iain A.
Afiliación
  • Swisher EM; Division of Gynecologic Oncology, University of Washington, Seattle, WA, USA. Electronic address: swishere@uw.edu.
  • Kristeleit RS; Department of Oncology, University College London (UCL) Cancer Institute and UCL Hospitals, London, UK.
  • Oza AM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Tinker AV; Medical Oncology, BC Cancer, Vancouver, BC, Canada.
  • Ray-Coquard I; Medical Oncology Department, Centre Léon Bérard and University Claude Bernard and Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Lyon, France.
  • Oaknin A; Gynecologic Cancer Program, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Coleman RL; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Burris HA; Sarah Cannon Research Institute at Tennessee Oncology, Nashville, TN, USA.
  • Aghajanian C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • O'Malley DM; Division of Gynecologic Oncology, The Ohio State University, James Cancer Center, Columbus, OH, USA.
  • Leary A; Gynecological Unit, Gustave Roussy Cancer Center, INSERM U981, and Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Villejuif, France.
  • Welch S; Division of Medical Oncology, Western University, London, ON, Canada.
  • Provencher D; Institut du Cancer de Montréal, Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, QC, Canada.
  • Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Chen LM; Gynecologic Oncology Division, University of California San Francisco, San Francisco, CA, USA.
  • Shapira-Frommer R; Department of Oncology, Chaim Sheba Medical Center, Tel HaShomer, Israel.
  • Kaufmann SH; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Goble S; Biostatistics, Clovis Oncology, Inc., Boulder, CO, USA.
  • Maloney L; Clinical Development, Clovis Oncology, Inc., Boulder, CO, USA.
  • Kwan T; Molecular Diagnostics, Clovis Oncology, Inc., Boulder, CO, USA.
  • Lin KK; Molecular Diagnostics, Clovis Oncology, Inc., Boulder, CO, USA.
  • McNeish IA; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Gynecol Oncol ; 163(3): 490-497, 2021 12.
Article en En | MEDLINE | ID: mdl-34602290
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Indoles / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Indoles / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2021 Tipo del documento: Article